Inhibitor binding to ACE (top) and ACE2 (bottom) highlight important differences between the active sites which control substrate specificity and type of peptidase activity. In this issue of Clinical Science (volume 134, issue 21), Lubbe et al. provide insight into the structural biology of ACE and ACE2, and highlight how it has improved our understanding of their functions.